Simulations Plus aims to boost growth through investments and partnerships, promoting innovation and increasing market opportunity. With over 25 years ...
Protagenic Therapeutics achieves milestone in Phase I trial for PT00114, a compound for treating stress-related neuro-psychiatric disorders. No adverse reactions ...